Dr Anthony Kameen Jr, MD | |
1104 Kenilworth Dr, Suite 400, Towson, MD 21204-2101 | |
(410) 339-7200 | |
(410) 339-7203 |
Full Name | Dr Anthony Kameen Jr |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Location | 1104 Kenilworth Dr, Towson, Maryland |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194807727 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | D0029917 (Maryland) | Primary |
Entity Name | Sea Island Ophthalmology |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700943743 PECOS PAC ID: 3476655523 Enrollment ID: O20070221000173 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Cyclobenzaprine Hydrochloride (HCl) Extended-release (ER) Capsules, 15 mg and 30 mg. Mylan was the first company to have filed a substantially complete ANDA containing a Paragraph IV certification for Cyclobenzaprine HCl ER Capsules and was awarded 180 days of marketing exclusivity.
A recent study conducted by Portuguese scientists has claimed that mRNA-based coronavirus disease 2019 (COVID-19) vaccines are less effective against the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Moreover, in breakthrough infections by delta variant, vaccines are less effective in reducing viral loads. The study is currently available on the medRxiv* preprint server.
Warner Chilcott plc today announced that its subsidiaries, Warner Chilcott Company, LLC and Warner Chilcott Finance LLC (together, the "Issuers"), plan to issue an aggregate principal amount of $500 million of 7-3/4% senior notes due 2018 (the "Notes") in a private placement. The notes are additional notes constituting a part of the same series as the $750 million aggregate principal amount of 7-3/4% senior notes due 2018 issued on August 20, 2010.
Porous polymer scaffolds fabricated to support the growth of biological tissue for implantation may hold the potential to greatly accelerate the development of cancer therapeutics.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Anthony Kameen Jr, MD 1104 Kenilworth Dr, Suite 400, Towson, MD 21204-2101 Ph: (410) 339-7200 | Dr Anthony Kameen Jr, MD 1104 Kenilworth Dr, Suite 400, Towson, MD 21204-2101 Ph: (410) 339-7200 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Cyclobenzaprine Hydrochloride (HCl) Extended-release (ER) Capsules, 15 mg and 30 mg. Mylan was the first company to have filed a substantially complete ANDA containing a Paragraph IV certification for Cyclobenzaprine HCl ER Capsules and was awarded 180 days of marketing exclusivity.
A recent study conducted by Portuguese scientists has claimed that mRNA-based coronavirus disease 2019 (COVID-19) vaccines are less effective against the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Moreover, in breakthrough infections by delta variant, vaccines are less effective in reducing viral loads. The study is currently available on the medRxiv* preprint server.
Warner Chilcott plc today announced that its subsidiaries, Warner Chilcott Company, LLC and Warner Chilcott Finance LLC (together, the "Issuers"), plan to issue an aggregate principal amount of $500 million of 7-3/4% senior notes due 2018 (the "Notes") in a private placement. The notes are additional notes constituting a part of the same series as the $750 million aggregate principal amount of 7-3/4% senior notes due 2018 issued on August 20, 2010.
Porous polymer scaffolds fabricated to support the growth of biological tissue for implantation may hold the potential to greatly accelerate the development of cancer therapeutics.
› Verified 3 days ago
Dr. Olga A Shif, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 901 Dulaney Valley Rd, The National Retina Institute, Towson, MD 21204 Phone: 410-337-4500 Fax: 410-339-7326 | |
Gary Lee Ehrlich, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 7401 Osler Dr, Suite 112, Towson, MD 21204 Phone: 410-828-8040 Fax: 410-828-8041 | |
Dr. Sudeep Pramanik, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 40 York Rd Ste 500, Towson, MD 21204 Phone: 410-616-9952 Fax: 443-927-7515 | |
Dr. Sanjay Desh Goel, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1104 Kenilworth Dr Ste 200, Towson, MD 21204 Phone: 410-888-2020 Fax: 667-223-1712 | |
Dr. Stanley J. Amernick, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 7505 Osler Dr, Ste 210, Towson, MD 21204 Phone: 410-321-1182 Fax: 410-337-2570 | |
Dr. Darab Hormozi, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8415 Bellona Ln, Suite 212, Towson, MD 21204 Phone: 410-825-4022 Fax: 410-825-6439 |